Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
DNA Copy Number Variations | 28 | 2023 | 1940 | 1.980 |
Why?
|
Genomics | 42 | 2024 | 5692 | 1.960 |
Why?
|
Brain Neoplasms | 41 | 2024 | 8829 | 1.870 |
Why?
|
Glioma | 25 | 2024 | 3388 | 1.710 |
Why?
|
Genome, Human | 32 | 2022 | 4420 | 1.690 |
Why?
|
Gene Dosage | 22 | 2020 | 1251 | 1.670 |
Why?
|
Aneuploidy | 6 | 2023 | 530 | 1.650 |
Why?
|
Neoplasms | 48 | 2023 | 21596 | 1.510 |
Why?
|
Meningioma | 16 | 2022 | 1209 | 1.370 |
Why?
|
Glioblastoma | 28 | 2024 | 3456 | 1.350 |
Why?
|
Meningeal Neoplasms | 16 | 2022 | 1241 | 1.180 |
Why?
|
Genomic Structural Variation | 4 | 2020 | 65 | 1.090 |
Why?
|
Loss of Heterozygosity | 7 | 2020 | 678 | 0.990 |
Why?
|
Mutation | 66 | 2024 | 29717 | 0.970 |
Why?
|
Chromosome Aberrations | 12 | 2018 | 1811 | 0.930 |
Why?
|
Gene Expression Regulation, Neoplastic | 39 | 2021 | 8425 | 0.930 |
Why?
|
Software | 7 | 2022 | 4434 | 0.920 |
Why?
|
Oncogenes | 15 | 2023 | 1263 | 0.870 |
Why?
|
Gene Amplification | 19 | 2018 | 1062 | 0.860 |
Why?
|
Azepines | 4 | 2019 | 336 | 0.850 |
Why?
|
Medulloblastoma | 5 | 2019 | 681 | 0.800 |
Why?
|
Cell Transformation, Neoplastic | 11 | 2023 | 2940 | 0.800 |
Why?
|
Genes, Essential | 3 | 2020 | 182 | 0.790 |
Why?
|
Cell Line, Tumor | 64 | 2021 | 16665 | 0.740 |
Why?
|
Genetics, Population | 2 | 2021 | 933 | 0.680 |
Why?
|
Astrocytoma | 3 | 2019 | 789 | 0.680 |
Why?
|
High-Throughput Nucleotide Sequencing | 17 | 2022 | 3585 | 0.680 |
Why?
|
Triazoles | 4 | 2019 | 907 | 0.670 |
Why?
|
INDEL Mutation | 3 | 2020 | 279 | 0.650 |
Why?
|
Evolution, Molecular | 6 | 2020 | 1937 | 0.640 |
Why?
|
Neural Stem Cells | 3 | 2020 | 847 | 0.640 |
Why?
|
Genes, Tumor Suppressor | 12 | 2023 | 1097 | 0.610 |
Why?
|
Sequence Deletion | 3 | 2018 | 1526 | 0.590 |
Why?
|
Cell Cycle | 6 | 2022 | 2964 | 0.580 |
Why?
|
Cerebellar Neoplasms | 3 | 2019 | 585 | 0.570 |
Why?
|
Oligonucleotide Array Sequence Analysis | 14 | 2015 | 3920 | 0.560 |
Why?
|
Gene Rearrangement | 11 | 2020 | 1179 | 0.530 |
Why?
|
Proto-Oncogenes | 1 | 2016 | 321 | 0.520 |
Why?
|
Publications | 1 | 2017 | 195 | 0.510 |
Why?
|
Neurogenesis | 2 | 2019 | 829 | 0.490 |
Why?
|
Stomach Neoplasms | 4 | 2020 | 1327 | 0.490 |
Why?
|
DNA Methylation | 9 | 2021 | 4282 | 0.480 |
Why?
|
Proto-Oncogene Proteins c-akt | 8 | 2018 | 2502 | 0.480 |
Why?
|
Gene Expression Profiling | 23 | 2019 | 9410 | 0.470 |
Why?
|
Neoplasm Proteins | 7 | 2020 | 3691 | 0.470 |
Why?
|
Phosphatidylinositol 3-Kinases | 12 | 2018 | 2938 | 0.470 |
Why?
|
DNA Mutational Analysis | 15 | 2020 | 4187 | 0.470 |
Why?
|
Cell Lineage | 8 | 2023 | 2504 | 0.460 |
Why?
|
Translocation, Genetic | 3 | 2016 | 1417 | 0.450 |
Why?
|
Humans | 211 | 2024 | 742088 | 0.450 |
Why?
|
Sequence Analysis, DNA | 10 | 2020 | 4801 | 0.440 |
Why?
|
Proto-Oncogene Proteins B-raf | 4 | 2019 | 2028 | 0.440 |
Why?
|
Carcinoma, Renal Cell | 6 | 2018 | 3123 | 0.440 |
Why?
|
Tumor Suppressor Protein p53 | 12 | 2022 | 2948 | 0.430 |
Why?
|
Endometrial Neoplasms | 7 | 2018 | 1351 | 0.420 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2016 | 651 | 0.420 |
Why?
|
MicroRNAs | 7 | 2021 | 3731 | 0.410 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2016 | 407 | 0.410 |
Why?
|
Kidney Neoplasms | 8 | 2021 | 4229 | 0.410 |
Why?
|
Polymorphism, Single Nucleotide | 27 | 2021 | 15494 | 0.400 |
Why?
|
Drug Resistance, Neoplasm | 13 | 2021 | 5163 | 0.400 |
Why?
|
Phosphoproteins | 3 | 2020 | 2440 | 0.390 |
Why?
|
RNA-Binding Proteins | 5 | 2021 | 1899 | 0.390 |
Why?
|
Enhancer Elements, Genetic | 2 | 2018 | 1337 | 0.390 |
Why?
|
Publishing | 1 | 2017 | 833 | 0.360 |
Why?
|
Carcinoma, Medullary | 2 | 2021 | 123 | 0.350 |
Why?
|
Oncogene Proteins, Fusion | 7 | 2021 | 1581 | 0.350 |
Why?
|
Chromosomes, Human, Pair 8 | 3 | 2023 | 462 | 0.340 |
Why?
|
Adaptor Proteins, Signal Transducing | 7 | 2020 | 2915 | 0.330 |
Why?
|
Receptors, G-Protein-Coupled | 2 | 2014 | 1221 | 0.330 |
Why?
|
Proto-Oncogene Proteins c-myc | 5 | 2019 | 987 | 0.330 |
Why?
|
bcl-X Protein | 4 | 2016 | 411 | 0.330 |
Why?
|
Computational Biology | 6 | 2021 | 3518 | 0.320 |
Why?
|
PTEN Phosphohydrolase | 9 | 2018 | 1144 | 0.320 |
Why?
|
Genetic Predisposition to Disease | 10 | 2021 | 17400 | 0.320 |
Why?
|
Nuclear Proteins | 12 | 2024 | 5851 | 0.320 |
Why?
|
von Hippel-Lindau Disease | 1 | 2009 | 152 | 0.310 |
Why?
|
Comparative Genomic Hybridization | 9 | 2017 | 496 | 0.310 |
Why?
|
Genomic Instability | 4 | 2019 | 695 | 0.310 |
Why?
|
Histones | 7 | 2024 | 2597 | 0.310 |
Why?
|
Adenocarcinoma | 7 | 2020 | 6347 | 0.300 |
Why?
|
DNA, Neoplasm | 11 | 2021 | 1758 | 0.300 |
Why?
|
Transcription Factors | 15 | 2024 | 12164 | 0.300 |
Why?
|
Oligodendroglia | 3 | 2020 | 514 | 0.290 |
Why?
|
Neoplasm Recurrence, Local | 10 | 2022 | 9185 | 0.290 |
Why?
|
Alleles | 8 | 2021 | 6931 | 0.290 |
Why?
|
Cell Proliferation | 19 | 2021 | 10472 | 0.280 |
Why?
|
Von Hippel-Lindau Tumor Suppressor Protein | 3 | 2020 | 290 | 0.280 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 3 | 2020 | 379 | 0.270 |
Why?
|
Hedgehog Proteins | 4 | 2014 | 781 | 0.270 |
Why?
|
Tumor Suppressor Proteins | 6 | 2018 | 2842 | 0.270 |
Why?
|
Epigenesis, Genetic | 9 | 2020 | 3639 | 0.270 |
Why?
|
Genetic Heterogeneity | 5 | 2021 | 732 | 0.270 |
Why?
|
Genes, Neoplasm | 5 | 2018 | 376 | 0.260 |
Why?
|
Proteins | 3 | 2019 | 6096 | 0.260 |
Why?
|
Signal Transduction | 32 | 2020 | 23387 | 0.260 |
Why?
|
Angiogenesis Inhibitors | 4 | 2019 | 2038 | 0.250 |
Why?
|
Genome | 3 | 2021 | 1803 | 0.250 |
Why?
|
Chromosomes, Human, Pair 14 | 3 | 2016 | 300 | 0.250 |
Why?
|
Models, Genetic | 6 | 2021 | 3493 | 0.250 |
Why?
|
Databases, Genetic | 7 | 2021 | 1780 | 0.250 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 6 | 2018 | 1683 | 0.250 |
Why?
|
Transcription, Genetic | 10 | 2021 | 7721 | 0.250 |
Why?
|
Cyclin-Dependent Kinase 4 | 3 | 2019 | 535 | 0.240 |
Why?
|
Mice | 41 | 2023 | 81045 | 0.240 |
Why?
|
Genes, p53 | 4 | 2015 | 755 | 0.240 |
Why?
|
MAP Kinase Signaling System | 3 | 2019 | 1525 | 0.240 |
Why?
|
Germ-Line Mutation | 3 | 2021 | 1786 | 0.240 |
Why?
|
DNA-Binding Proteins | 10 | 2020 | 9639 | 0.240 |
Why?
|
Mice, Nude | 13 | 2019 | 3689 | 0.240 |
Why?
|
In Situ Hybridization, Fluorescence | 11 | 2019 | 2638 | 0.240 |
Why?
|
Pituitary Neoplasms | 3 | 2017 | 1340 | 0.230 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 3 | 2019 | 1114 | 0.230 |
Why?
|
Chromatin | 4 | 2020 | 2917 | 0.220 |
Why?
|
Jaundice, Neonatal | 1 | 2003 | 71 | 0.220 |
Why?
|
Thyrotoxicosis | 1 | 2003 | 82 | 0.220 |
Why?
|
Gene Fusion | 4 | 2016 | 371 | 0.220 |
Why?
|
Neuroblastoma | 2 | 2022 | 1225 | 0.220 |
Why?
|
Chromosomes, Human, Pair 5 | 2 | 2014 | 403 | 0.220 |
Why?
|
Esophageal Neoplasms | 5 | 2020 | 1581 | 0.210 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 5 | 2018 | 890 | 0.210 |
Why?
|
Neoplasms, Neuroepithelial | 1 | 2022 | 45 | 0.210 |
Why?
|
Centromere | 1 | 2023 | 220 | 0.210 |
Why?
|
Vaccinia | 1 | 2022 | 76 | 0.210 |
Why?
|
Proto-Oncogene Proteins | 7 | 2022 | 4553 | 0.210 |
Why?
|
Haplotypes | 4 | 2021 | 2781 | 0.200 |
Why?
|
Proteasome Endopeptidase Complex | 4 | 2019 | 1333 | 0.200 |
Why?
|
Cell Cycle Proteins | 8 | 2024 | 3444 | 0.200 |
Why?
|
Animals | 49 | 2023 | 168561 | 0.200 |
Why?
|
Prostatic Neoplasms | 10 | 2010 | 11039 | 0.200 |
Why?
|
Graves Disease | 1 | 2003 | 241 | 0.200 |
Why?
|
ras GTPase-Activating Proteins | 2 | 2013 | 101 | 0.200 |
Why?
|
Neoplasm Metastasis | 9 | 2018 | 4839 | 0.190 |
Why?
|
Molecular Targeted Therapy | 6 | 2019 | 2723 | 0.190 |
Why?
|
Dacarbazine | 2 | 2015 | 567 | 0.190 |
Why?
|
Maternal-Fetal Exchange | 1 | 2003 | 455 | 0.190 |
Why?
|
Cloning, Organism | 1 | 2020 | 54 | 0.190 |
Why?
|
Tachykinins | 1 | 2021 | 78 | 0.190 |
Why?
|
Trans-Activators | 5 | 2013 | 2924 | 0.190 |
Why?
|
Apoptosis | 9 | 2020 | 9715 | 0.190 |
Why?
|
Peptide Nucleic Acids | 1 | 2020 | 24 | 0.180 |
Why?
|
Xenograft Model Antitumor Assays | 6 | 2020 | 3557 | 0.180 |
Why?
|
S Phase | 2 | 2019 | 423 | 0.180 |
Why?
|
Neoplasm Invasiveness | 8 | 2018 | 3612 | 0.180 |
Why?
|
DNA Primase | 1 | 2020 | 109 | 0.180 |
Why?
|
Neoplasm Transplantation | 8 | 2019 | 2085 | 0.180 |
Why?
|
Chromosomes, Human, Pair 1 | 4 | 2019 | 657 | 0.170 |
Why?
|
Cyclin D2 | 1 | 2019 | 101 | 0.170 |
Why?
|
Death Domain Receptor Signaling Adaptor Proteins | 1 | 2019 | 34 | 0.170 |
Why?
|
Telomere | 2 | 2023 | 909 | 0.170 |
Why?
|
Melanoma | 5 | 2022 | 5462 | 0.170 |
Why?
|
Phenotype | 12 | 2021 | 16331 | 0.170 |
Why?
|
Cluster Analysis | 6 | 2016 | 2713 | 0.170 |
Why?
|
Telomerase | 4 | 2020 | 729 | 0.170 |
Why?
|
Retroelements | 1 | 2020 | 164 | 0.160 |
Why?
|
Algorithms | 10 | 2022 | 13853 | 0.160 |
Why?
|
Protein Tyrosine Phosphatases, Non-Receptor | 1 | 2018 | 66 | 0.160 |
Why?
|
Gene Deletion | 9 | 2020 | 2751 | 0.160 |
Why?
|
Tumor Cells, Cultured | 5 | 2019 | 6313 | 0.160 |
Why?
|
Genes, myc | 3 | 2018 | 399 | 0.160 |
Why?
|
Chromosome Deletion | 7 | 2018 | 1400 | 0.160 |
Why?
|
Interleukin-9 | 1 | 2018 | 63 | 0.160 |
Why?
|
Chromosomes, Human, Pair 3 | 3 | 2018 | 323 | 0.160 |
Why?
|
Receptors, Androgen | 2 | 2018 | 1057 | 0.160 |
Why?
|
Morpholines | 2 | 2019 | 561 | 0.160 |
Why?
|
Antineoplastic Agents | 9 | 2019 | 13655 | 0.160 |
Why?
|
Phosphatidylinositol 3-Kinase | 1 | 2019 | 130 | 0.160 |
Why?
|
Cyclin-Dependent Kinase 6 | 2 | 2019 | 322 | 0.160 |
Why?
|
Quinazolines | 4 | 2015 | 1355 | 0.160 |
Why?
|
Oligonucleotides, Antisense | 1 | 2020 | 433 | 0.150 |
Why?
|
Histone-Lysine N-Methyltransferase | 2 | 2013 | 670 | 0.150 |
Why?
|
Protein Kinase Inhibitors | 7 | 2023 | 5522 | 0.150 |
Why?
|
Long Interspersed Nucleotide Elements | 1 | 2020 | 338 | 0.150 |
Why?
|
Pyridazines | 1 | 2019 | 201 | 0.150 |
Why?
|
Female | 66 | 2022 | 379592 | 0.150 |
Why?
|
Ubiquitin-Protein Ligases | 3 | 2016 | 1860 | 0.150 |
Why?
|
Male | 61 | 2022 | 349538 | 0.150 |
Why?
|
Salvage Therapy | 2 | 2014 | 1269 | 0.150 |
Why?
|
Ubiquitin Thiolesterase | 2 | 2018 | 449 | 0.150 |
Why?
|
Aminopyridines | 2 | 2019 | 541 | 0.150 |
Why?
|
Genetic Variation | 5 | 2020 | 6540 | 0.150 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2018 | 234 | 0.150 |
Why?
|
RNA, Neoplasm | 3 | 2016 | 768 | 0.150 |
Why?
|
Lung Neoplasms | 8 | 2021 | 13019 | 0.150 |
Why?
|
Indazoles | 1 | 2018 | 287 | 0.150 |
Why?
|
Cell Survival | 8 | 2020 | 5872 | 0.140 |
Why?
|
Metabolic Networks and Pathways | 3 | 2020 | 782 | 0.140 |
Why?
|
Urothelium | 1 | 2019 | 277 | 0.140 |
Why?
|
ras Proteins | 4 | 2015 | 1060 | 0.140 |
Why?
|
Neoplasms, Second Primary | 2 | 2022 | 1052 | 0.140 |
Why?
|
DNA Repair | 4 | 2024 | 2042 | 0.140 |
Why?
|
ADP-Ribosylation Factor 1 | 1 | 2016 | 43 | 0.140 |
Why?
|
RNA Interference | 7 | 2019 | 2890 | 0.140 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 2 | 2022 | 1038 | 0.140 |
Why?
|
GATA2 Transcription Factor | 1 | 2016 | 161 | 0.140 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 5 | 2020 | 704 | 0.140 |
Why?
|
Histone Demethylases | 1 | 2019 | 320 | 0.140 |
Why?
|
RNA, Small Interfering | 7 | 2014 | 3504 | 0.140 |
Why?
|
Genes, X-Linked | 1 | 2016 | 128 | 0.140 |
Why?
|
Oncogene Proteins v-myb | 1 | 2016 | 26 | 0.140 |
Why?
|
Ploidies | 2 | 2013 | 281 | 0.140 |
Why?
|
Virus Integration | 1 | 2018 | 297 | 0.140 |
Why?
|
Chromosomes, Human | 2 | 2016 | 457 | 0.140 |
Why?
|
Ear Neoplasms | 1 | 2016 | 117 | 0.140 |
Why?
|
Disease Progression | 14 | 2019 | 13256 | 0.140 |
Why?
|
Interneurons | 1 | 2020 | 576 | 0.140 |
Why?
|
Cyclin E | 2 | 2014 | 172 | 0.130 |
Why?
|
Mitogen-Activated Protein Kinases | 2 | 2019 | 1284 | 0.130 |
Why?
|
NF-E2-Related Factor 2 | 2 | 2015 | 364 | 0.130 |
Why?
|
STAT6 Transcription Factor | 1 | 2016 | 199 | 0.130 |
Why?
|
Receptor, trkB | 1 | 2016 | 125 | 0.130 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 2 | 2018 | 1377 | 0.130 |
Why?
|
Chromosomes, Human, Pair 6 | 1 | 2016 | 380 | 0.130 |
Why?
|
Endometrial Hyperplasia | 1 | 2016 | 96 | 0.130 |
Why?
|
Drug Carriers | 1 | 2020 | 692 | 0.130 |
Why?
|
Insulin-Like Growth Factor II | 1 | 2016 | 271 | 0.130 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2018 | 647 | 0.130 |
Why?
|
Sequence Alignment | 2 | 2017 | 2257 | 0.130 |
Why?
|
Disease-Free Survival | 8 | 2018 | 6891 | 0.130 |
Why?
|
Documentation | 1 | 2021 | 865 | 0.130 |
Why?
|
Chromosomes, Human, X | 1 | 2016 | 296 | 0.130 |
Why?
|
Rhabdoid Tumor | 1 | 2017 | 212 | 0.130 |
Why?
|
Prognosis | 12 | 2022 | 29010 | 0.130 |
Why?
|
Ovarian Neoplasms | 6 | 2014 | 4823 | 0.130 |
Why?
|
Oncogene Proteins | 3 | 2014 | 749 | 0.130 |
Why?
|
Adenoma, Oxyphilic | 1 | 2016 | 143 | 0.130 |
Why?
|
Oligodendroglioma | 2 | 2014 | 279 | 0.120 |
Why?
|
X Chromosome Inactivation | 1 | 2016 | 224 | 0.120 |
Why?
|
Abdominal Neoplasms | 1 | 2016 | 290 | 0.120 |
Why?
|
Craniopharyngioma | 1 | 2017 | 281 | 0.120 |
Why?
|
Cytosine | 1 | 2015 | 216 | 0.120 |
Why?
|
Genome-Wide Association Study | 6 | 2020 | 12220 | 0.120 |
Why?
|
Quantitative Trait Loci | 1 | 2022 | 2015 | 0.120 |
Why?
|
Vestibule, Labyrinth | 1 | 2016 | 235 | 0.120 |
Why?
|
Bacterial Toxins | 1 | 2020 | 933 | 0.120 |
Why?
|
Antigens, Bacterial | 1 | 2020 | 1170 | 0.120 |
Why?
|
Astrocytes | 3 | 2020 | 1266 | 0.120 |
Why?
|
Immunohistochemistry | 8 | 2016 | 11363 | 0.120 |
Why?
|
Pelvic Neoplasms | 1 | 2016 | 254 | 0.120 |
Why?
|
Mutagenesis | 2 | 2020 | 1263 | 0.120 |
Why?
|
Mice, Inbred NOD | 5 | 2020 | 1875 | 0.120 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 2 | 2012 | 1434 | 0.120 |
Why?
|
Proto-Oncogene Proteins c-met | 2 | 2015 | 578 | 0.120 |
Why?
|
Semantics | 1 | 2017 | 584 | 0.120 |
Why?
|
Methyl-CpG-Binding Protein 2 | 1 | 2015 | 191 | 0.120 |
Why?
|
Antineoplastic Agents, Alkylating | 2 | 2020 | 627 | 0.120 |
Why?
|
Chromosome Mapping | 4 | 2016 | 4742 | 0.120 |
Why?
|
GRB10 Adaptor Protein | 1 | 2013 | 22 | 0.120 |
Why?
|
Chromosomes | 1 | 2017 | 595 | 0.120 |
Why?
|
Intracellular Signaling Peptides and Proteins | 5 | 2022 | 2906 | 0.110 |
Why?
|
Acetyl-CoA Carboxylase | 1 | 2013 | 78 | 0.110 |
Why?
|
Pentose Phosphate Pathway | 1 | 2013 | 124 | 0.110 |
Why?
|
Piperidines | 3 | 2018 | 1602 | 0.110 |
Why?
|
Imidazoles | 1 | 2019 | 1205 | 0.110 |
Why?
|
Child | 17 | 2024 | 77478 | 0.110 |
Why?
|
Precancerous Conditions | 1 | 2020 | 971 | 0.110 |
Why?
|
Oncogenic Viruses | 1 | 2012 | 42 | 0.110 |
Why?
|
Somatostatin | 1 | 2014 | 459 | 0.110 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2014 | 430 | 0.110 |
Why?
|
Ependymoma | 1 | 2016 | 333 | 0.110 |
Why?
|
Adult | 33 | 2024 | 213712 | 0.110 |
Why?
|
Drug Synergism | 1 | 2016 | 1791 | 0.110 |
Why?
|
Chromosome Breakage | 1 | 2012 | 173 | 0.100 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 2 | 2010 | 250 | 0.100 |
Why?
|
Citric Acid Cycle | 1 | 2013 | 231 | 0.100 |
Why?
|
Cyclin D1 | 1 | 2014 | 462 | 0.100 |
Why?
|
Breast Neoplasms | 9 | 2018 | 20774 | 0.100 |
Why?
|
Hydroxamic Acids | 1 | 2015 | 495 | 0.100 |
Why?
|
Neurofibromin 2 | 1 | 2013 | 267 | 0.100 |
Why?
|
Genetic Techniques | 2 | 2012 | 435 | 0.100 |
Why?
|
Neurofibromin 1 | 2 | 2012 | 196 | 0.100 |
Why?
|
Genetic Testing | 2 | 2014 | 3439 | 0.100 |
Why?
|
Phosphoglycerate Dehydrogenase | 1 | 2011 | 38 | 0.100 |
Why?
|
Genetic Association Studies | 3 | 2021 | 2699 | 0.100 |
Why?
|
Middle Aged | 34 | 2020 | 213127 | 0.100 |
Why?
|
Aged | 30 | 2020 | 162944 | 0.100 |
Why?
|
Interferon-gamma | 1 | 2020 | 3199 | 0.100 |
Why?
|
Survival Analysis | 5 | 2018 | 10248 | 0.100 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 1 | 2016 | 484 | 0.100 |
Why?
|
Microsatellite Repeats | 2 | 2020 | 800 | 0.100 |
Why?
|
Protein Methyltransferases | 1 | 2011 | 55 | 0.100 |
Why?
|
Probability | 2 | 2007 | 2502 | 0.100 |
Why?
|
Clone Cells | 3 | 2020 | 1692 | 0.100 |
Why?
|
Microglia | 1 | 2019 | 1261 | 0.100 |
Why?
|
Neurilemmoma | 1 | 2016 | 547 | 0.100 |
Why?
|
DNA Breaks | 2 | 2021 | 49 | 0.100 |
Why?
|
Isocitrate Dehydrogenase | 4 | 2019 | 870 | 0.100 |
Why?
|
Trisomy | 1 | 2012 | 266 | 0.090 |
Why?
|
Cerebrum | 1 | 2012 | 137 | 0.090 |
Why?
|
Parietal Lobe | 1 | 2016 | 837 | 0.090 |
Why?
|
Biotechnology | 2 | 2012 | 278 | 0.090 |
Why?
|
Polymerase Chain Reaction | 5 | 2007 | 6171 | 0.090 |
Why?
|
Stathmin | 1 | 2010 | 71 | 0.090 |
Why?
|
Extracellular Matrix Proteins | 1 | 2015 | 849 | 0.090 |
Why?
|
RNA | 1 | 2020 | 2747 | 0.090 |
Why?
|
Dogs | 1 | 2015 | 3910 | 0.090 |
Why?
|
Neoplasms, Glandular and Epithelial | 1 | 2014 | 484 | 0.090 |
Why?
|
Multigene Family | 2 | 2013 | 1102 | 0.090 |
Why?
|
Disease Models, Animal | 8 | 2022 | 18006 | 0.090 |
Why?
|
Protein Processing, Post-Translational | 2 | 2015 | 1989 | 0.090 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 3 | 2016 | 11472 | 0.090 |
Why?
|
Haploinsufficiency | 1 | 2012 | 329 | 0.090 |
Why?
|
Carcinoma, Papillary | 1 | 2015 | 781 | 0.090 |
Why?
|
Virology | 1 | 2010 | 77 | 0.090 |
Why?
|
Genes, ras | 2 | 2010 | 691 | 0.090 |
Why?
|
T-Box Domain Proteins | 1 | 2012 | 471 | 0.090 |
Why?
|
Histiocytoma, Malignant Fibrous | 1 | 2010 | 63 | 0.090 |
Why?
|
Serine Endopeptidases | 3 | 2016 | 1073 | 0.090 |
Why?
|
Promoter Regions, Genetic | 6 | 2020 | 5867 | 0.090 |
Why?
|
Carrier Proteins | 4 | 2021 | 5019 | 0.090 |
Why?
|
Receptors, HIV | 1 | 2010 | 162 | 0.090 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2013 | 608 | 0.090 |
Why?
|
Malformations of Cortical Development | 1 | 2012 | 200 | 0.090 |
Why?
|
Spinal Neoplasms | 1 | 2016 | 759 | 0.090 |
Why?
|
DNA Damage | 2 | 2022 | 2423 | 0.090 |
Why?
|
Sequence Analysis, RNA | 4 | 2019 | 2011 | 0.080 |
Why?
|
Base Sequence | 4 | 2014 | 12797 | 0.080 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2014 | 859 | 0.080 |
Why?
|
Sulfonamides | 1 | 2018 | 1932 | 0.080 |
Why?
|
DNA Helicases | 3 | 2024 | 861 | 0.080 |
Why?
|
Pregnancy Complications | 1 | 2003 | 2861 | 0.080 |
Why?
|
Chromosomes, Human, Pair 13 | 1 | 2009 | 199 | 0.080 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2013 | 628 | 0.080 |
Why?
|
Lymphoma, B-Cell | 1 | 2015 | 930 | 0.080 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2014 | 1769 | 0.080 |
Why?
|
Models, Biological | 4 | 2020 | 9581 | 0.080 |
Why?
|
Protein Binding | 6 | 2021 | 9387 | 0.080 |
Why?
|
Chromosomes, Human, Pair 4 | 1 | 2009 | 374 | 0.080 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2018 | 4029 | 0.080 |
Why?
|
Adenosine Triphosphatases | 1 | 2013 | 836 | 0.080 |
Why?
|
Mice, SCID | 4 | 2016 | 2715 | 0.080 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 2011 | 520 | 0.080 |
Why?
|
Gene Frequency | 2 | 2020 | 3587 | 0.080 |
Why?
|
NF-kappa B | 3 | 2014 | 2500 | 0.080 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 5 | 2013 | 5171 | 0.080 |
Why?
|
Child, Preschool | 8 | 2022 | 40955 | 0.080 |
Why?
|
Gene Regulatory Networks | 2 | 2013 | 1707 | 0.080 |
Why?
|
Proto-Oncogene Proteins c-ets | 1 | 2009 | 318 | 0.080 |
Why?
|
Neoadjuvant Therapy | 1 | 2019 | 2721 | 0.080 |
Why?
|
SOXB1 Transcription Factors | 1 | 2009 | 284 | 0.080 |
Why?
|
BRCA1 Protein | 1 | 2014 | 1145 | 0.080 |
Why?
|
Tumor Microenvironment | 2 | 2022 | 3564 | 0.080 |
Why?
|
Cranial Irradiation | 1 | 2010 | 401 | 0.080 |
Why?
|
DNA Repair Enzymes | 2 | 2024 | 349 | 0.080 |
Why?
|
Recombination, Genetic | 1 | 2012 | 1586 | 0.080 |
Why?
|
Karnofsky Performance Status | 2 | 2019 | 173 | 0.080 |
Why?
|
Gene Expression | 3 | 2022 | 7790 | 0.080 |
Why?
|
Repressor Proteins | 2 | 2016 | 3020 | 0.080 |
Why?
|
beta Catenin | 1 | 2012 | 1058 | 0.080 |
Why?
|
Membrane Transport Proteins | 1 | 2013 | 1028 | 0.080 |
Why?
|
Cholangiocarcinoma | 1 | 2013 | 516 | 0.070 |
Why?
|
Immunotherapy, Adoptive | 3 | 2022 | 1255 | 0.070 |
Why?
|
Central Nervous System Neoplasms | 1 | 2016 | 895 | 0.070 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2011 | 627 | 0.070 |
Why?
|
env Gene Products, Human Immunodeficiency Virus | 1 | 2010 | 370 | 0.070 |
Why?
|
Oxygen | 1 | 2019 | 4169 | 0.070 |
Why?
|
Glycolysis | 1 | 2011 | 825 | 0.070 |
Why?
|
Liposarcoma | 1 | 2010 | 333 | 0.070 |
Why?
|
Seizures | 2 | 2024 | 2851 | 0.070 |
Why?
|
Mutagenesis, Insertional | 2 | 2020 | 655 | 0.070 |
Why?
|
Aged, 80 and over | 14 | 2019 | 57683 | 0.070 |
Why?
|
Survivors | 2 | 2014 | 2286 | 0.070 |
Why?
|
Adenoma | 1 | 2017 | 2168 | 0.070 |
Why?
|
Chromosomes, Human, Pair 19 | 2 | 2019 | 366 | 0.070 |
Why?
|
Cohort Studies | 10 | 2022 | 40450 | 0.070 |
Why?
|
Indoles | 1 | 2015 | 1834 | 0.070 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2014 | 1509 | 0.070 |
Why?
|
Virus Internalization | 1 | 2010 | 501 | 0.070 |
Why?
|
Kaplan-Meier Estimate | 5 | 2015 | 6534 | 0.070 |
Why?
|
Colonic Neoplasms | 3 | 2012 | 2542 | 0.070 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2019 | 2229 | 0.070 |
Why?
|
Survival Rate | 6 | 2015 | 12773 | 0.070 |
Why?
|
Saposins | 1 | 2005 | 27 | 0.070 |
Why?
|
Young Adult | 12 | 2022 | 56350 | 0.070 |
Why?
|
Clinical Trials as Topic | 2 | 2022 | 7901 | 0.070 |
Why?
|
src-Family Kinases | 3 | 2015 | 551 | 0.070 |
Why?
|
Carcinoma, Ductal, Breast | 3 | 2008 | 1101 | 0.070 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 2009 | 774 | 0.070 |
Why?
|
Transplantation, Heterologous | 4 | 2017 | 2382 | 0.070 |
Why?
|
DNA Modification Methylases | 2 | 2018 | 206 | 0.070 |
Why?
|
Chromosomes, Human, Y | 1 | 2006 | 148 | 0.060 |
Why?
|
HEK293 Cells | 3 | 2022 | 4200 | 0.060 |
Why?
|
Membrane Glycoproteins | 1 | 2016 | 3769 | 0.060 |
Why?
|
Cyclin-Dependent Kinases | 3 | 2018 | 670 | 0.060 |
Why?
|
Neoplasms, Experimental | 3 | 2020 | 1274 | 0.060 |
Why?
|
Genotype | 7 | 2021 | 12946 | 0.060 |
Why?
|
Viral Proteins | 1 | 2012 | 1899 | 0.060 |
Why?
|
Retrospective Studies | 12 | 2023 | 77098 | 0.060 |
Why?
|
Bacillus Phages | 1 | 2004 | 12 | 0.060 |
Why?
|
Enzyme Activation | 3 | 2019 | 3701 | 0.060 |
Why?
|
Tissue Engineering | 1 | 2015 | 1877 | 0.060 |
Why?
|
Gene Duplication | 2 | 2018 | 330 | 0.060 |
Why?
|
Adolescent | 10 | 2022 | 85649 | 0.060 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2012 | 987 | 0.060 |
Why?
|
Neurofibromatosis 1 | 1 | 2009 | 562 | 0.060 |
Why?
|
Infant | 5 | 2022 | 35070 | 0.060 |
Why?
|
DNA | 2 | 2021 | 7289 | 0.060 |
Why?
|
Host-Pathogen Interactions | 1 | 2012 | 1477 | 0.060 |
Why?
|
Carcinoma, Small Cell | 1 | 2005 | 420 | 0.050 |
Why?
|
RNA, Messenger | 4 | 2022 | 13029 | 0.050 |
Why?
|
Molecular Sequence Data | 5 | 2014 | 18112 | 0.050 |
Why?
|
raf Kinases | 2 | 2016 | 122 | 0.050 |
Why?
|
Combined Modality Therapy | 4 | 2018 | 8621 | 0.050 |
Why?
|
Bayes Theorem | 2 | 2023 | 2303 | 0.050 |
Why?
|
Mice, Knockout | 4 | 2020 | 14554 | 0.050 |
Why?
|
Longitudinal Studies | 1 | 2018 | 13921 | 0.050 |
Why?
|
Protein-Tyrosine Kinases | 2 | 2008 | 2455 | 0.050 |
Why?
|
Protein Structure, Tertiary | 4 | 2013 | 3847 | 0.050 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 1 | 2024 | 437 | 0.050 |
Why?
|
Mutation, Missense | 2 | 2011 | 2556 | 0.050 |
Why?
|
Proteomics | 1 | 2015 | 3618 | 0.050 |
Why?
|
Artificial Intelligence | 1 | 2014 | 2187 | 0.050 |
Why?
|
Kruppel-Like Transcription Factors | 2 | 2014 | 504 | 0.050 |
Why?
|
Androgens | 2 | 2009 | 1271 | 0.050 |
Why?
|
Diploidy | 1 | 2021 | 138 | 0.050 |
Why?
|
DNA-Directed DNA Polymerase | 1 | 2004 | 484 | 0.050 |
Why?
|
Radiosurgery | 1 | 2010 | 1309 | 0.050 |
Why?
|
DEAD-box RNA Helicases | 2 | 2014 | 375 | 0.050 |
Why?
|
Data Interpretation, Statistical | 2 | 2008 | 2714 | 0.050 |
Why?
|
Vaccinia virus | 1 | 2022 | 349 | 0.050 |
Why?
|
Methylnitrosourea | 1 | 2020 | 29 | 0.050 |
Why?
|
Genes, Lethal | 1 | 2021 | 242 | 0.050 |
Why?
|
Gene Silencing | 2 | 2020 | 1538 | 0.050 |
Why?
|
Chromosome Inversion | 1 | 2020 | 127 | 0.050 |
Why?
|
Infant, Newborn | 2 | 2015 | 25575 | 0.050 |
Why?
|
Core Binding Factor Alpha 2 Subunit | 2 | 2012 | 345 | 0.050 |
Why?
|
Fanconi Anemia Complementation Group Proteins | 1 | 2020 | 100 | 0.040 |
Why?
|
Cerebral Hemorrhage | 1 | 2011 | 2643 | 0.040 |
Why?
|
Open Reading Frames | 2 | 2014 | 810 | 0.040 |
Why?
|
3T3 Cells | 2 | 2013 | 1101 | 0.040 |
Why?
|
Brain Stem Neoplasms | 1 | 2022 | 204 | 0.040 |
Why?
|
Chromosome Segregation | 1 | 2021 | 236 | 0.040 |
Why?
|
Sensitivity and Specificity | 4 | 2010 | 14720 | 0.040 |
Why?
|
Succinate Dehydrogenase | 1 | 2020 | 146 | 0.040 |
Why?
|
Liver Neoplasms | 2 | 2013 | 4249 | 0.040 |
Why?
|
RNA Helicases | 1 | 2020 | 142 | 0.040 |
Why?
|
NIH 3T3 Cells | 2 | 2014 | 677 | 0.040 |
Why?
|
Pyridines | 3 | 2018 | 2818 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2022 | 380 | 0.040 |
Why?
|
Biphenyl Compounds | 2 | 2014 | 914 | 0.040 |
Why?
|
Treatment Outcome | 5 | 2018 | 62966 | 0.040 |
Why?
|
Kidney | 2 | 2019 | 7167 | 0.040 |
Why?
|
Glucose | 1 | 2011 | 4391 | 0.040 |
Why?
|
Nervous System | 1 | 2022 | 553 | 0.040 |
Why?
|
Phylogeny | 2 | 2016 | 2797 | 0.040 |
Why?
|
Pathology, Molecular | 1 | 2022 | 325 | 0.040 |
Why?
|
Mammary Glands, Human | 2 | 2013 | 200 | 0.040 |
Why?
|
STAT1 Transcription Factor | 1 | 2020 | 320 | 0.040 |
Why?
|
Receptor, TIE-2 | 1 | 2019 | 178 | 0.040 |
Why?
|
Random Allocation | 1 | 2023 | 2425 | 0.040 |
Why?
|
Neoplasm Staging | 4 | 2015 | 11001 | 0.040 |
Why?
|
Sarcoma | 1 | 2010 | 1895 | 0.040 |
Why?
|
Prosencephalon | 1 | 2020 | 303 | 0.040 |
Why?
|
Tissue Array Analysis | 2 | 2010 | 553 | 0.040 |
Why?
|
Ki-67 Antigen | 2 | 2012 | 644 | 0.040 |
Why?
|
Brain Mapping | 1 | 2014 | 6669 | 0.040 |
Why?
|
Germ Cells | 1 | 2022 | 628 | 0.040 |
Why?
|
TOR Serine-Threonine Kinases | 2 | 2018 | 2107 | 0.040 |
Why?
|
Hypoxia-Inducible Factor 1 | 1 | 2019 | 198 | 0.040 |
Why?
|
MAP Kinase Kinase 1 | 1 | 2020 | 337 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinase 7 | 1 | 2018 | 66 | 0.040 |
Why?
|
Cells, Cultured | 4 | 2020 | 19223 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 5 | 2017 | 35342 | 0.040 |
Why?
|
Receptor, erbB-2 | 1 | 2008 | 2410 | 0.040 |
Why?
|
Jumonji Domain-Containing Histone Demethylases | 1 | 2019 | 182 | 0.040 |
Why?
|
Streptococcus pyogenes | 1 | 2020 | 289 | 0.040 |
Why?
|
Blotting, Western | 3 | 2011 | 5180 | 0.040 |
Why?
|
Zebrafish | 3 | 2014 | 2990 | 0.040 |
Why?
|
Cell Shape | 1 | 2018 | 375 | 0.040 |
Why?
|
Receptors, Cell Surface | 3 | 2014 | 2867 | 0.040 |
Why?
|
Janus Kinase 2 | 1 | 2020 | 527 | 0.040 |
Why?
|
Pyrimidines | 3 | 2018 | 2933 | 0.040 |
Why?
|
DNA Mismatch Repair | 1 | 2020 | 424 | 0.040 |
Why?
|
Binding Sites | 2 | 2021 | 6115 | 0.040 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 1 | 2019 | 544 | 0.040 |
Why?
|
Chromogranins | 1 | 2017 | 163 | 0.040 |
Why?
|
DNA Breaks, Double-Stranded | 1 | 2021 | 589 | 0.040 |
Why?
|
Interferons | 1 | 2020 | 704 | 0.040 |
Why?
|
Models, Molecular | 3 | 2015 | 5454 | 0.040 |
Why?
|
Cell Hypoxia | 1 | 2019 | 675 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2019 | 552 | 0.030 |
Why?
|
World Health Organization | 1 | 2022 | 1317 | 0.030 |
Why?
|
Proportional Hazards Models | 3 | 2015 | 12344 | 0.030 |
Why?
|
Methylation | 1 | 2019 | 1107 | 0.030 |
Why?
|
Cell Division | 3 | 2009 | 4564 | 0.030 |
Why?
|
Lysine | 1 | 2020 | 1008 | 0.030 |
Why?
|
Anticoagulants | 1 | 2011 | 4595 | 0.030 |
Why?
|
TNF Receptor-Associated Factor 3 | 1 | 2015 | 40 | 0.030 |
Why?
|
Pyrimidinones | 1 | 2018 | 370 | 0.030 |
Why?
|
Octamer Transcription Factor-3 | 1 | 2016 | 223 | 0.030 |
Why?
|
Follow-Up Studies | 5 | 2015 | 39004 | 0.030 |
Why?
|
Barrett Esophagus | 1 | 2020 | 494 | 0.030 |
Why?
|
In Situ Hybridization | 2 | 2013 | 1950 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2009 | 4751 | 0.030 |
Why?
|
Hospitalization | 1 | 2015 | 10232 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-raf | 1 | 2016 | 203 | 0.030 |
Why?
|
GTP-Binding Protein alpha Subunits, Gs | 1 | 2017 | 202 | 0.030 |
Why?
|
Anilides | 1 | 2018 | 404 | 0.030 |
Why?
|
Phosphorylation | 3 | 2015 | 8436 | 0.030 |
Why?
|
BRCA2 Protein | 1 | 2020 | 790 | 0.030 |
Why?
|
Cell Line | 4 | 2012 | 15994 | 0.030 |
Why?
|
5-Methylcytosine | 1 | 2015 | 153 | 0.030 |
Why?
|
MAP Kinase Kinase Kinases | 1 | 2016 | 261 | 0.030 |
Why?
|
Cell Movement | 3 | 2014 | 5212 | 0.030 |
Why?
|
Reproducibility of Results | 4 | 2018 | 19862 | 0.030 |
Why?
|
Predictive Value of Tests | 3 | 2016 | 15056 | 0.030 |
Why?
|
Telomere-Binding Proteins | 1 | 2015 | 116 | 0.030 |
Why?
|
Epistasis, Genetic | 1 | 2017 | 365 | 0.030 |
Why?
|
Neoplastic Stem Cells | 2 | 2017 | 1376 | 0.030 |
Why?
|
Adaptor Proteins, Vesicular Transport | 1 | 2016 | 315 | 0.030 |
Why?
|
Embryo, Mammalian | 1 | 2020 | 1692 | 0.030 |
Why?
|
Lomustine | 1 | 2014 | 59 | 0.030 |
Why?
|
Carmustine | 1 | 2014 | 137 | 0.030 |
Why?
|
Endpoint Determination | 1 | 2017 | 600 | 0.030 |
Why?
|
Receptors, Somatostatin | 1 | 2014 | 129 | 0.030 |
Why?
|
Homozygote | 2 | 2012 | 1777 | 0.030 |
Why?
|
Organoids | 1 | 2020 | 692 | 0.030 |
Why?
|
F-Box Proteins | 1 | 2015 | 197 | 0.030 |
Why?
|
Teratoma | 1 | 2016 | 387 | 0.030 |
Why?
|
Ubiquitin | 1 | 2019 | 849 | 0.030 |
Why?
|
Stem Cells | 1 | 2007 | 3563 | 0.030 |
Why?
|
Mice, Transgenic | 2 | 2020 | 9735 | 0.030 |
Why?
|
Mitochondria | 2 | 2016 | 3520 | 0.030 |
Why?
|
Pyridones | 1 | 2018 | 712 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-yes | 1 | 2012 | 16 | 0.030 |
Why?
|
Ribosomal Protein S6 Kinases | 1 | 2013 | 205 | 0.030 |
Why?
|
Transcriptional Activation | 2 | 2010 | 1782 | 0.030 |
Why?
|
Wnt Proteins | 1 | 2017 | 721 | 0.030 |
Why?
|
Species Specificity | 1 | 2017 | 2479 | 0.030 |
Why?
|
Microscopy, Electron, Scanning | 1 | 2015 | 962 | 0.030 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2020 | 1820 | 0.030 |
Why?
|
Chromosome Breakpoints | 1 | 2012 | 98 | 0.030 |
Why?
|
G1 Phase | 1 | 2014 | 415 | 0.030 |
Why?
|
Hepatocyte Nuclear Factor 1-beta | 1 | 2012 | 94 | 0.030 |
Why?
|
Hemizygote | 1 | 2012 | 28 | 0.030 |
Why?
|
Core Binding Factor beta Subunit | 1 | 2012 | 45 | 0.030 |
Why?
|
MutS Homolog 2 Protein | 1 | 2013 | 200 | 0.030 |
Why?
|
DNA Polymerase II | 1 | 2013 | 107 | 0.030 |
Why?
|
Selection, Genetic | 1 | 2017 | 914 | 0.030 |
Why?
|
Exosomes | 1 | 2017 | 412 | 0.030 |
Why?
|
HIV-1 | 1 | 2010 | 6934 | 0.030 |
Why?
|
Base Composition | 1 | 2012 | 293 | 0.030 |
Why?
|
Obesity | 1 | 2015 | 12705 | 0.030 |
Why?
|
Maximum Tolerated Dose | 1 | 2014 | 891 | 0.030 |
Why?
|
Mice, Inbred C57BL | 2 | 2020 | 21821 | 0.030 |
Why?
|
Genes, p16 | 1 | 2012 | 157 | 0.030 |
Why?
|
E2F Transcription Factors | 1 | 2012 | 274 | 0.030 |
Why?
|
bcl-2 Homologous Antagonist-Killer Protein | 1 | 2012 | 75 | 0.030 |
Why?
|
Transforming Growth Factor beta | 2 | 2012 | 2006 | 0.030 |
Why?
|
Muscle Proteins | 1 | 2017 | 1159 | 0.030 |
Why?
|
Inhibitor of Apoptosis Proteins | 1 | 2012 | 215 | 0.030 |
Why?
|
Polyomavirus | 1 | 2012 | 248 | 0.020 |
Why?
|
Vietnam | 1 | 2012 | 408 | 0.020 |
Why?
|
Bile Ducts, Intrahepatic | 1 | 2013 | 295 | 0.020 |
Why?
|
Two-Hybrid System Techniques | 1 | 2012 | 464 | 0.020 |
Why?
|
Time Factors | 3 | 2021 | 40054 | 0.020 |
Why?
|
CpG Islands | 1 | 2015 | 1170 | 0.020 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2016 | 1158 | 0.020 |
Why?
|
Enzyme Inhibitors | 2 | 2013 | 3800 | 0.020 |
Why?
|
Chromatography, Liquid | 1 | 2015 | 977 | 0.020 |
Why?
|
Protein Isoforms | 1 | 2015 | 1727 | 0.020 |
Why?
|
Neoplasm, Residual | 1 | 2015 | 974 | 0.020 |
Why?
|
Crystallography, X-Ray | 1 | 2015 | 2014 | 0.020 |
Why?
|
Protein Interaction Mapping | 1 | 2014 | 627 | 0.020 |
Why?
|
High-Throughput Screening Assays | 1 | 2016 | 944 | 0.020 |
Why?
|
Testicular Neoplasms | 1 | 2016 | 761 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2019 | 3471 | 0.020 |
Why?
|
SEER Program | 1 | 2015 | 1507 | 0.020 |
Why?
|
Alternative Splicing | 1 | 2015 | 1118 | 0.020 |
Why?
|
Consensus | 1 | 2019 | 2935 | 0.020 |
Why?
|
Mexico | 1 | 2012 | 688 | 0.020 |
Why?
|
Nerve Tissue Proteins | 2 | 2014 | 4465 | 0.020 |
Why?
|
GTPase-Activating Proteins | 1 | 2013 | 497 | 0.020 |
Why?
|
Genes, Homeobox | 1 | 2011 | 286 | 0.020 |
Why?
|
Transfection | 2 | 2009 | 5892 | 0.020 |
Why?
|
Immunoenzyme Techniques | 1 | 2013 | 1799 | 0.020 |
Why?
|
Tumor Burden | 1 | 2015 | 1905 | 0.020 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2015 | 789 | 0.020 |
Why?
|
Immunoblotting | 1 | 2013 | 1683 | 0.020 |
Why?
|
Ultraviolet Rays | 1 | 2014 | 1059 | 0.020 |
Why?
|
Genes, Recessive | 1 | 2012 | 642 | 0.020 |
Why?
|
Nuclear Receptor Coactivator 3 | 1 | 2009 | 53 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2022 | 3455 | 0.020 |
Why?
|
Nevus | 1 | 2011 | 204 | 0.020 |
Why?
|
Blister | 1 | 2009 | 85 | 0.020 |
Why?
|
Hepatocyte Nuclear Factor 3-alpha | 1 | 2009 | 170 | 0.020 |
Why?
|
Tandem Mass Spectrometry | 1 | 2015 | 1157 | 0.020 |
Why?
|
Genetic Loci | 1 | 2018 | 2572 | 0.020 |
Why?
|
Drug Delivery Systems | 1 | 2020 | 2217 | 0.020 |
Why?
|
Exons | 1 | 2014 | 2431 | 0.020 |
Why?
|
Platelet Count | 1 | 2011 | 780 | 0.020 |
Why?
|
Ubiquitin-Conjugating Enzymes | 1 | 2009 | 195 | 0.020 |
Why?
|
Prostate-Specific Antigen | 1 | 2018 | 2458 | 0.020 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2013 | 713 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2019 | 3502 | 0.020 |
Why?
|
Blood Coagulation Factors | 1 | 2010 | 355 | 0.020 |
Why?
|
Luciferases | 1 | 2010 | 733 | 0.020 |
Why?
|
Adenoviridae | 1 | 2012 | 1096 | 0.020 |
Why?
|
HeLa Cells | 1 | 2014 | 3127 | 0.020 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2011 | 892 | 0.020 |
Why?
|
Computer Simulation | 2 | 2012 | 6191 | 0.020 |
Why?
|
Recurrence | 1 | 2019 | 8333 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2018 | 2183 | 0.020 |
Why?
|
Receptors, Notch | 1 | 2012 | 739 | 0.020 |
Why?
|
Spinal Cord | 1 | 2016 | 1807 | 0.020 |
Why?
|
Melanocytes | 1 | 2011 | 515 | 0.020 |
Why?
|
Bile Duct Neoplasms | 1 | 2013 | 567 | 0.020 |
Why?
|
Biopsy, Needle | 1 | 2013 | 1640 | 0.020 |
Why?
|
Protein Conformation | 1 | 2015 | 4013 | 0.020 |
Why?
|
Sirolimus | 1 | 2014 | 1562 | 0.020 |
Why?
|
Chromosomes, Human, Pair 10 | 1 | 2008 | 287 | 0.020 |
Why?
|
Herpesvirus 4, Human | 1 | 2012 | 1040 | 0.020 |
Why?
|
Ligands | 1 | 2014 | 3293 | 0.020 |
Why?
|
Histone Acetyltransferases | 1 | 2009 | 336 | 0.020 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2014 | 2014 | 0.020 |
Why?
|
Point Mutation | 1 | 2012 | 1624 | 0.020 |
Why?
|
Immunophenotyping | 1 | 2011 | 1866 | 0.020 |
Why?
|
Small Molecule Libraries | 1 | 2012 | 721 | 0.020 |
Why?
|
Cell Separation | 1 | 2012 | 1749 | 0.020 |
Why?
|
Incidence | 2 | 2015 | 20928 | 0.020 |
Why?
|
Amino Acid Substitution | 1 | 2011 | 1792 | 0.020 |
Why?
|
Genes, Reporter | 1 | 2010 | 1547 | 0.020 |
Why?
|
Papillomaviridae | 1 | 2012 | 1118 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2015 | 6365 | 0.020 |
Why?
|
Animals, Genetically Modified | 1 | 2011 | 1546 | 0.020 |
Why?
|
DNA Replication | 1 | 2012 | 1397 | 0.020 |
Why?
|
Risk Factors | 3 | 2020 | 72145 | 0.020 |
Why?
|
Pregnancy | 2 | 2007 | 29087 | 0.020 |
Why?
|
Environmental Exposure | 1 | 2020 | 4231 | 0.020 |
Why?
|
5' Untranslated Regions | 1 | 2006 | 249 | 0.020 |
Why?
|
Genes, erbB-2 | 1 | 2005 | 162 | 0.020 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2008 | 625 | 0.020 |
Why?
|
Genes, erbB-1 | 1 | 2005 | 161 | 0.020 |
Why?
|
Substrate Specificity | 1 | 2009 | 1802 | 0.020 |
Why?
|
Plasmids | 1 | 2010 | 2305 | 0.020 |
Why?
|
DNA Primers | 1 | 2009 | 2892 | 0.020 |
Why?
|
Immunotherapy | 1 | 2020 | 4414 | 0.020 |
Why?
|
Pharmacogenetics | 1 | 2008 | 676 | 0.020 |
Why?
|
Colon | 1 | 2012 | 1773 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2015 | 6483 | 0.020 |
Why?
|
Protein Kinase C | 1 | 2009 | 1227 | 0.020 |
Why?
|
Cytokines | 1 | 2019 | 7317 | 0.020 |
Why?
|
Neurosurgical Procedures | 1 | 2015 | 2002 | 0.020 |
Why?
|
Age of Onset | 1 | 2011 | 3266 | 0.010 |
Why?
|
Lymph Nodes | 1 | 2015 | 3465 | 0.010 |
Why?
|
HIV Infections | 1 | 2010 | 16678 | 0.010 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2009 | 1372 | 0.010 |
Why?
|
Proteome | 1 | 2013 | 1790 | 0.010 |
Why?
|
Microphthalmia-Associated Transcription Factor | 1 | 2005 | 251 | 0.010 |
Why?
|
Microarray Analysis | 1 | 2005 | 766 | 0.010 |
Why?
|
Chemokines, CXC | 1 | 2004 | 422 | 0.010 |
Why?
|
Nucleic Acid Hybridization | 1 | 2004 | 1374 | 0.010 |
Why?
|
Pilot Projects | 1 | 2015 | 8297 | 0.010 |
Why?
|
Chemokine CXCL12 | 1 | 2004 | 462 | 0.010 |
Why?
|
B-Lymphocytes | 1 | 2015 | 4664 | 0.010 |
Why?
|
Down-Regulation | 1 | 2009 | 3001 | 0.010 |
Why?
|
Thiazoles | 1 | 2008 | 1484 | 0.010 |
Why?
|
Gene Library | 1 | 2004 | 1076 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2012 | 5975 | 0.010 |
Why?
|
Research Design | 1 | 2017 | 5979 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2013 | 10943 | 0.010 |
Why?
|
Internet | 1 | 2012 | 3062 | 0.010 |
Why?
|
Muscle, Smooth | 1 | 2004 | 933 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 2005 | 4322 | 0.010 |
Why?
|
Antigens, Neoplasm | 1 | 2008 | 1983 | 0.010 |
Why?
|
Epithelium | 1 | 2004 | 1680 | 0.010 |
Why?
|
Hemorrhage | 1 | 2011 | 3461 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2014 | 12958 | 0.010 |
Why?
|
Risk | 1 | 2011 | 9679 | 0.010 |
Why?
|
Pediatrics | 1 | 2014 | 3462 | 0.010 |
Why?
|
Models, Theoretical | 1 | 2011 | 3584 | 0.010 |
Why?
|
Pulmonary Embolism | 1 | 2011 | 2370 | 0.010 |
Why?
|
Age Factors | 1 | 2015 | 18355 | 0.010 |
Why?
|
Carcinoma in Situ | 1 | 2004 | 802 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2015 | 10163 | 0.010 |
Why?
|
Databases, Factual | 1 | 2013 | 7716 | 0.010 |
Why?
|
Body Mass Index | 1 | 2015 | 12695 | 0.010 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2009 | 2211 | 0.010 |
Why?
|
Epilepsy | 1 | 2012 | 3301 | 0.010 |
Why?
|
Antigens, CD | 1 | 2007 | 4024 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2012 | 7873 | 0.010 |
Why?
|
Breast | 1 | 2004 | 1958 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2009 | 11470 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2008 | 9274 | 0.010 |
Why?
|
Prospective Studies | 1 | 2015 | 53187 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 2014 | 15108 | 0.010 |
Why?
|
Brain | 1 | 2014 | 26343 | 0.000 |
Why?
|